Fairview Capital Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.1M Sell
159,955
-6,331
-4% -$1.47M 2.12% 12
2025
Q4
$34.4M Sell
166,286
-12,138
-7% -$2.4M 1.77% 19
2025
Q3
$33.1M Sell
178,424
-4,379
-2% -$750K 1.68% 19
2025
Q2
$27.9M Sell
182,803
-12,021
-6% -$1.85M 1.44% 21
2025
Q1
$32.3M Sell
194,824
-9,930
-5% -$1.55M 1.71% 19
2024
Q4
$29.6M Sell
204,754
-11,564
-5% -$1.79M 1.54% 22
2024
Q3
$35.1M Sell
216,318
-9,283
-4% -$1.48M 1.9% 20
2024
Q2
$33M Sell
225,601
-69,021
-23% -$10.3M 1.85% 19
2024
Q1
$46.6M Sell
294,622
-67,941
-19% -$10.8M 2.63% 12
2023
Q4
$56.8M Sell
362,563
-12,042
-3% -$1.85M 3.38% 8
2023
Q3
$58.3M Sell
374,605
-2,668
-0.7% -$440K 3.74% 6
2023
Q2
$62.4M Sell
377,273
-5,880
-2% -$949K 3.95% 7
2023
Q1
$59.4M Buy
383,153
+1,657
+0.4% +$268K 3.88% 8
2022
Q4
$67.4M Buy
381,496
+2,151
+0.6% +$371K 4.61% 3
2022
Q3
$62M Buy
379,345
+3,024
+0.8% +$512K 4.42% 5
2022
Q2
$66.8M Buy
376,321
+905
+0.2% +$161K 4.63% 5
2022
Q1
$66.5M Buy
375,416
+8,552
+2% +$1.46M 4.15% 8
2021
Q4
$62.8M Buy
366,864
+5,493
+2% +$899K 4.02% 8
2021
Q3
$58.4M Buy
361,371
+2,068
+0.6% +$353K 3.98% 7
2021
Q2
$59.2M Buy
359,303
+8,660
+2% +$1.43M 4.07% 8
2021
Q1
$57.6M Buy
350,643
+7,835
+2% +$1.27M 2.07% 11
2020
Q4
$54M Buy
342,808
+6,603
+2% +$974K 2.21% 12
2020
Q3
$50.1M Sell
336,205
-10,558
-3% -$1.56M 2.35% 13
2020
Q2
$48.8M Sell
346,763
-1,775
-0.5% -$259K 2.36% 14
2020
Q1
$45.7M Buy
348,538
+3,134
+0.9% +$445K 2.71% 11
2019
Q4
$50.4M Buy
345,404
+4,052
+1% +$550K 2.48% 14
2019
Q3
$44.2M Sell
341,352
-1,170
-0.3% -$154K 2.19% 15
2019
Q2
$47.7M Sell
342,522
-324
-0.1% -$44.8K 2.4% 12
2019
Q1
$47.9M Buy
342,846
+14,723
+4% +$1.97M 2.57% 13
2018
Q4
$42.3M Buy
328,123
+1,483
+0.5% +$207K 2.52% 15
2018
Q3
$45.1M Sell
326,640
-1,584
-0.5% -$210K 2.55% 12
2018
Q2
$39.8M Buy
328,224
+35,933
+12% +$4.48M 2.32% 17
2018
Q1
$37.5M Buy
292,291
+6,095
+2% +$824K 2.36% 17
2017
Q4
$40M Buy
286,196
+309
+0.1% +$43K 2.43% 16
2017
Q3
$37.2M Buy
285,887
+945
+0.3% +$125K 2.34% 17
2017
Q2
$37.7M Buy
284,942
+800
+0.3% +$102K 2.47% 14
2017
Q1
$35.4M Sell
284,142
-3,557
-1% -$425K 2.53% 13
2016
Q4
$33.1M Buy
287,699
+1,035
+0.4% +$120K 2.46% 13
2016
Q3
$33.9M Buy
286,664
+875
+0.3% +$106K 2.59% 12
2016
Q2
$34.7M Sell
285,789
-2,030
-0.7% -$231K 2.82% 8
2016
Q1
$31.1M Buy
287,819
+2,980
+1% +$309K 2.58% 9
2015
Q4
$29.3M Sell
284,839
-3,508
-1% -$353K 2.48% 12
2015
Q3
$26.9M Buy
288,347
+5,185
+2% +$502K 2.38% 13
2015
Q2
$27.6M Buy
283,162
+8,199
+3% +$821K 2.29% 13
2015
Q1
$27.7M Buy
274,963
+70
+0% +$7.12K 2.23% 14
2014
Q4
$28.7M Sell
274,893
-350
-0.1% -$36.9K 2.3% 13
2014
Q3
$29.3M Buy
275,243
+979
+0.4% +$102K 2.38% 10
2014
Q2
$28.7M Buy
274,264
+3,400
+1% +$344K 2.33% 11
2014
Q1
$26.6M Buy
270,864
+3,925
+1% +$364K 2.24% 11
2013
Q4
$24.4M Sell
266,939
-6,708
-2% -$618K 2.14% 13
2013
Q3
$23.7M Buy
273,647
+440
+0.2% +$39.5K 2.26% 12
2013
Q2
$23.5M Buy
+273,207
New +$23.2M 2.42% 11

Other funds holding JNJ

Fairview Capital Investment Management's JNJ Position: Q1 2026 in Review

Fairview Capital Investment Management reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q1 2026, selling an estimated $1.47M and leaving 159,955 shares worth $39.1M. The position accounts for 2.12% of the portfolio, ranked #12.

Fairview Capital Investment Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $67.4M in Q4 2022. 4,619 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Fairview Capital Investment Management held 159,955 shares of Johnson & Johnson worth $39.1M as of Q1 2026.
  • Fairview Capital Investment Management sold 6,331 Johnson & Johnson shares in Q1 2026, an estimated $1.47M.
  • Johnson & Johnson made up 2.12% of Fairview Capital Investment Management's portfolio in Q1 2026, its #12 holding.
  • Fairview Capital Investment Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Fairview Capital Investment Management's Johnson & Johnson position peaked at $67.4M in Q4 2022.
  • 4,619 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Fairview Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.